Brain white matter microstructure following SARS-CoV2 infection
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202011FBD
Grant search
Key facts
Disease
COVID-19Start & end year
20202023Known Financial Commitments (USD)
$78,750Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
Concordia UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
In the Spring of 2020, the lives of people worldwide have changed in unimaginable ways. Activities that were once deemed normal everyday activities now require careful consideration, weighing the potential risks against the benefits. Decisions are now made in regards to what is deemed safe, or of an acceptable level of risk, on a daily basis. In order to make these decisions, it is important to be fully aware of the impact that contracting the SARS-CoV2 virus can have on overall health. Importantly, several cases have been reported where SARS-CoV2 infection led to neurological symptoms including severe headache, nausea, loss of smell and taste, and even stroke. A large amount of evidence now shows that the virus can not only enter but also damage the brain, and, in some cases, this damage can prove to be fatal. Although there are known neurological complications to Covid-19, much remains unknown concerning the mechanisms at play. In this project, we will study the impact of Covid-19 on the brain, especially on white matter (the connective pathways between neurons) and cognition, using brain imaging techniques (MRI) and cognitive tests. We will also explore how risk factors, such as hypertension, diabetes, and smoking, influence the impact that Covid-19 has on white matter and cognition, as the presence of these risk factors has been shown to increase the risk of neurological complications with Covid-19. Neurological pathologies have a high incidence in Covid-19 patients, occurring in over one third of patients. These neurological complications lead to severe symptoms and high mortality rates. Our goal is to uncover the type of damage that can occur within the brain following SARS-CoV2 infection. We hope this study will be the first step in designing effective prevention and intervention programs to reduce the incidence and severity of neurological complications with Covid-19 in future research.